NL-OMON49617
Recruiting
Not Applicable
Reduced Microvascular Blood Volume as a Driver of Coronary Microvascular Disease in Patients with Non Obstructive Coronary Artery Disease - MICORDIS study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 61
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient group:
- •\- Age \> 40 years
- •\- Signed informed consent
- •\- Stable and chronic symptoms suggesting ischemic heart disease
- •\- NOCAD on coronary angiography: coronary artery stenosis \<\= 50% and/or FFR \>
- •\- Prior transthoracic echocardiographic assessment
- •Control group:
- •\- Age \> 40 years
- •\- Signed informed consent36 bgc
Exclusion Criteria
- •\- Age \> 80 years
- •\- Obstructive coronary artery disease, defined as more than 50% obstruction of
- •any coronary artery
- •\- FFR \< 0\.80
- •\- Use of medication for the control group
- •\- Persons working at the department of Cardiology from the VU university
- •medical centre
- •\- Persons involved in the study
- •\- Family (partner, parents, child, brother or sister or statutory person) from
- •persons working at the department of Cardiology from the VU university medical
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Reduced Microvascular Blood Volume as a Driver of Coronary Microvascular Disease in Patients with Non-Obstructive Coronary Artery Disease: The MICORDIS-studyNL-OMON23861Amsterdam UMC56
Completed
Not Applicable
Microvascular flow and microvascular blood volume measurements in human skeletal muscle using contrast enhanced ultrasound (CEUS).microvascular insulin resistanceobesity1001842410057166NL-OMON38401niversiteit Maastricht8
Active, not recruiting
Not Applicable
Discovering beneficial properties of ticagrelor in acute myocardialinfarctioST elevation myocardial infarction (STEMI)Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2014-005363-33-ESVU university medical center110
Active, not recruiting
Phase 1
Discovering beneficial properties of ticagrelor in acute myocardial infarctioST elevation myocardial infarction (STEMI)Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2014-005363-33-NLVU university medical center110
Completed
Not Applicable
Reducing Micro Vascular dysfunction In revascularized STEMI patients by off-target properties of ticagrelorNL-OMON44678Vrije Universiteit Medisch Centrum110